Vote Scores
Filings read through

How funds voted at Rapt Therapeutics, Inc.

Filers reporting
144, year to 30 June 2025
Latest meeting on file
Meetings on file
2

In the year to 30 June 2025, 144 filers on Form N-PX reported votes at Rapt Therapeutics, Inc.. The votes fall in one meeting. The figures count the filers that report on Form N-PX and the shares they reported. They do not count all votes cast at the meeting. Filers gave 503 marks to the ballot items, each with or against management. 65.2% of the marks are with management.

On say-on-pay, 114 of the 138 reporting filers that marked the item voted against management. This is 82.6% of the filers. Of the reported shares, 27.7% went against management. The median of the 3,794 companies on this site with a say-on-pay item is 8.1% of filers and 4.0% of reported shares.

At the meeting of 29 May 2025, 3 fund families have a say-on-pay position with management and 27 have a position against management.

By filers reporting in the year to 30 June 2025, Rapt Therapeutics, Inc. was number 2,953 of 11,807 companies with a page and votes in that year. The number of filers reporting at Rapt Therapeutics, Inc. rose by 67.4% from the year to 30 June 2024 to the year to 30 June 2025. At the companies on this site with filers in both years, the total of filers reporting rose by 4.1%. In all seasons on file, category DIRECTOR ELECTIONS is 38.3% of the vote records at Rapt Therapeutics, Inc.. At all companies on this site, it is 52.2%.

ForAgainstAbstain, withhold or otherAmber tick: the part cast against management

If the reporting person has not received confirmation of the actual number of votes cast prior to filing a report on Form N-PX, the numbers reported may reflect the number of shares instructed to be cast. A reporting person is not required to amend a previously filed Form N-PX report if the reporting person subsequently receives confirmation of the actual number of votes cast.

The words of the SEC. Source: Form N-PX and its instructions, Special Instructions D.5 and D.8, copied on .

The words of this site: the filer writes each filing. The SEC does not say that it checked the votes. A lender does not vote shares that are on loan. A later filing (Form N-PX/A) can replace an earlier filing, and the site uses the latest.

The figures on this page count the filers that report on Form N-PX and the shares they reported. They do not count all votes cast at the meeting.

The page gives records. It gives no investment advice and no advice on how to vote.

Season on this page: year to 30 June 2025. Filings read through . How the figures are made

Since the last update

The site has recorded no change in the tracked figures of this page.

Tracked: the meetings on file and the date of the latest meeting. All recorded changes

The ballot of 29 May 2025

144 filers reported votes at this meeting in the year to 30 June 2025. The items are in ballot order: the company's items first, then proposals from security holders. Each bar shows how the reporting filers split. It is not the result of the meeting. The meeting page has the split by reported shares and a CSV file.

  1. Item 1: Director elections

    1 nominee. 10.3% of the reported votes are for. 49 filers withheld from or voted against at least one nominee.

    97 vote records from 57 filers. 48 of the 57 filers that marked the item voted against management.

    • Positions of 23 fund families
    • For 3
    • Abstain or withhold 20
    • Against management 20
  2. Item 2: Advisory vote on executive pay (say-on-pay)

    200 vote records from 143 filers. 114 of the 138 filers that marked the item voted against management. 5 filers gave no management mark.

    • Positions of 30 fund families
    • For 2
    • Against 27
    • Split or no vote 1
    • Against management 27
  3. Item 3: Frequency of the say-on-pay vote

    One year: 126 filers. Three years: 5 filers. For: 4 filers. Abstain: 1 filer. Against: 1 filer. None: 1 filer.

    200 vote records from 142 filers. 6 of the 137 filers that marked the item voted against management. 5 filers gave no management mark.

    • Positions of 30 fund families
    • Split or no vote 30
    • Against management 2
  4. Item 4: Audit-related items (auditor ratification)

    97 vote records from 57 filers. 0 of the 57 filers that marked the item voted against management.

    • Positions of 23 fund families
    • For 23
  5. Item 5: CAPITAL STRUCTURE: management items

    The company's items in this category are shown together, because filers word and number them differently.

    103 vote records from 57 filers. 2 of the 57 filers that marked the item voted against management.

    • Positions of 23 fund families
    • For 22
    • Against 1
    • Against management 1
  6. Item 6: COMPENSATION: management items

    The company's items in this category are shown together, because filers word and number them differently.

    188 vote records from 57 filers. 5 of the 57 filers that marked the item voted against management.

    • Positions of 23 fund families
    • Against 1
    • Split or no vote 22
    • Against management 1

Positions of the fund families at the meeting of 29 May 2025

A position is not the vote of each fund. The position of a family is the way most of the shares reported by its filers were voted. Funds of one family can vote in different ways.

KeyForAgainstAbstain or withholdSplit or no voteAgainst management

Fund families at Rapt Therapeutics, Inc., meeting of 29 May 2025Families in name order. "Abstain" includes withhold. "Split" includes no vote. "No report" means that no filer of the family listed the item.
Fund familySay-on-pay
AllianceBernsteinAgainst, against management
BlackRock and iSharesAgainst, against management
BNY MellonAgainst, against management
Charles SchwabAgainst, against management
DimensionalAgainst, against management
DWSAgainst, against management
EquitableAgainst, against management
Federated HermesAgainst, against management
FidelityAgainst, against management
First TrustSplit
Global XAgainst, against management
Goldman SachsAgainst, against management
Guggenheim and RydexAgainst, against management
InvescoAgainst, against management
J.P. MorganAgainst, against management
Jackson National fundsAgainst, against management
Lincoln FinancialFor
Morgan Stanley, Eaton Vance and CalvertAgainst, against management
NationwideAgainst, against management
Northern Trust and FlexSharesAgainst, against management
Nuveen and TIAAAgainst, against management
Pacific Life fundsAgainst, against management
PGIM and PrudentialAgainst, against management
PrincipalAgainst, against management
ProShares and ProFundsAgainst, against management
Russell InvestmentsAgainst, against management
SEIAgainst, against management
State Street and SPDRFor
T. Rowe PriceAgainst, against management
VanguardAgainst, against management

Every meeting on file

Meetings of Rapt Therapeutics, Inc., from Form N-PX filings, newest firstA meeting with 20 or more reporting filers has its own page. Dates up to three days apart count as one meeting.
MeetingSeasonFilers reportingItemsFilers against management on say-on-pay
year to 30 June 2025144682.6%
year to 30 June 2024862not reported

Say-on-pay, season by season

Say-on-pay at Rapt Therapeutics, Inc.: filers reporting on Form N-PXThe share of filers, and of the shares they reported, that voted against management.
SeasonFilers reportingFilers against managementReported shares against management
year to 30 June 202514482.6%27.7%
year to 30 June 202486not reportednot reported
Rapt Therapeutics, Inc. and the median of companies on this site, year to 30 June 2025
Say-on-payThis companyMedian of companies on this site
Filers against management82.6%8.1%
Reported shares against management27.7%4.0%

The median covers 3,794 companies. Each has a say-on-pay item that 20 or more filers reported. The two figures are not a grade. The median is a reference only.

Vote records at Rapt Therapeutics, Inc. by category, every seasonThe category is the one each filer chose.
CategoryVote recordsShare
DIRECTOR ELECTIONS59238.3%
SECTION 14A SAY-ON-PAY VOTES40025.9%
AUDIT-RELATED26217.0%
CAPITAL STRUCTURE1036.7%
COMPENSATION18812.2%

The record at the SEC

Each link loaded on .

Cite this page

Vote Scores. How funds voted at Rapt Therapeutics, Inc.. https://votescores.com/company/rapt-therapeutics-inc/. Source: SEC EDGAR, Form N-PX and N-PX/A filings read through .

Questions

How many meetings of Rapt Therapeutics, Inc. are on file?
2 meetings are on file, from 22 May 2024 to 29 May 2025. 2 meetings have 20 or more reporting filers and have their own page.
Did filers report proposals from security holders at Rapt Therapeutics, Inc.?
Not enough filers reported a proposal from security holders for the site to show one in the year to 30 June 2025. The ballot shows the items that filers did report.
Is this the meeting result?
No. The figures count the filers that report on Form N-PX and the shares they reported. Other holders are not in the count. Rapt Therapeutics, Inc. reports the result of a vote on Form 8-K.
How does the site group meetings and names?
Filers type company names and meeting dates themselves. The site groups spellings of one company name. It treats meeting dates up to three days apart as one meeting. The data runs through 13 Nov 2026.

Provenance: SEC EDGAR, Form N-PX and N-PX/A filings that list Rapt Therapeutics, Inc., grouped by company. The name is the most common spelling among filers. The filers wrote the filings. Filings read through .